Topics

COVID-19 induces a reliable immune response after 15 days as measured by antibody levels in blood

18:38 EDT 26 Mar 2020 | GMO pundit




As serological assays begin to identify people with presumed immunity to #COVID19#SARSCoV2—the first who will restore our societies—understanding antibody response timing is critical. This study of 173 patients suggests ~15 days to robust IgM/IgG levels David R. Liu@davidrliu on Twitter
Pre-print here (pdf)
ResultsAmong 173 patients, the seroconversion rate for Ab, IgM and IgG was 93.1% (161/173), 82.7% (143/173) and 64.7% (112/173), respectively. Twelve patients who had not seroconverted were those only blood samples at the early stage of illness were collected. The seroconversion sequentially appeared for Ab, IgM and then IgG, with a median time of 11, 12 and 14 days, respectively. The presence of antibodies was < 40% among patients in the first 7 days of illness, and then rapidly increased to 100.0%, 94.3% and 79.8% for Ab, IgM and IgG respectively since day 15 after onset. In contrast, the positive rate of RNA decreased from 66.7% (58/87) in samples collected before day 7 to 45.5% (25/55) during days 15 to 39. Combining RNA and antibody detections significantly improved the sensitivity of pathogenic diagnosis for COVID-19 patients (p < 0.001), even in early phase of 1-week since onset (p = 0.007). Moreover, a higher titer of Ab was independently associated with a worse clinical classification (p = 0.006). ConclusionsThe antibody detection offers vital clinical information during the course of SARS-CoV2 infection. The findings provide strong empirical support for the routine application of serological testing in the diagnosis and management of COVID-19 patients.

Prof. Zheng Zhang, PhD, MD. Institute of Hepatology, Shenzhen 3rd People’s Hospital, Shenzhen 518112, Guangdong Province, China
Email: zhangzheng1975@aliyun.com. Prof. Lei Liu, MD, Shenzhen 3rd People’s Hospital, Shenzhen 518112, Guangdong Province, China; Email: liulei3322@aliyun.com. Prof. Sheng-Xiang Ge, PhD, The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China; Phone: 86-0592-2184110; Fax: 86-0592-2181258; Email: sxge@xmu.edu.cn. Prof. Jun Zhang, MSc, The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen 361102, China; Phone: 86-0592-2184110; Fax: 86- 0592-2181258; Email: zhangj@xmu.edu.cn.

See also




Original Article: COVID-19 induces a reliable immune response after 15 days as measured by antibody levels in blood

NEXT ARTICLE

More From BioPortfolio on "COVID-19 induces a reliable immune response after 15 days as measured by antibody levels in blood"

Quick Search

Relevant Topics

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...